Answers are grounded in this paper and cite their sources.
Genome sequencing is increasingly being considered as a first-line genetic test in routine clinical settings and can make a substantial contribution to rapidly identifying a causal aetiology for many patients, shortening their diagnostic odyssey. We have demonstrated that structural, splice site and intronic variants make a significant contribution to diagnostic yield and that comprehensive analysis of the entire genome is essential to maximise the value of clinical genome sequencing.
No takes yet. Share an insight, caveat, or question.
Pagnamenta et al. (2023) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: